Literature DB >> 29255377

Breast tuberculosis: a report of five cases.

Boubacar Efared1, Ibrahim S Sidibé1, Fatimazahra Erregad1, Nawal Hammas1,2, Laila Chbani1,2, Hinde El Fatemi1,2.   

Abstract

BACKGROUND: Breast tuberculosis is a rare form of extrapulmonary tuberculosis with clinical and radiological misleading presentations. We report herein a retrospective study of clinicopathological features of five cases of breast tuberculosis collected at Hassan II University Hospital of Fès, Morocco, a country where tuberculosis is endemic. CASE
PRESENTATION: The mean age was 40.6 years (range of 21-59 years). Two patients presented with abscessed lesions, and three cases presented with breast lumps with a suspicion of malignancy on imaging techniques. The diagnosis has been made on histological specimens (3 biopsy specimens, 1 excisional biopsy, and 1 lumpectomy). All patients have been successfully treated after the completion of the standard antibiotherapy.
CONCLUSIONS: Our current study shows that the breast is rarely affected by tuberculosis even in endemic area. The clinical presentation is often misleading, and the histopathological analysis constitutes a valuable diagnostic tool. The prognosis of breast tuberculosis is good after treatment by a standard antibiotherapy.

Entities:  

Keywords:  Breast; Caseous necrosis; Endemic; Morocco; Tuberculosis

Year:  2017        PMID: 29255377      PMCID: PMC5729462          DOI: 10.1186/s41182-017-0081-6

Source DB:  PubMed          Journal:  Trop Med Health        ISSN: 1348-8945


Background

Breast tuberculosis (BTB) is a very rare form of extrapulmonary tuberculosis (EPTB) even in endemic areas of the world [1, 2]. The incidence of BTB ranges from 0.1% in developed countries to 4.5% in endemic countries [2, 3]. The breast gland, as well as the spleen or the skeletal muscle, is a hostile milieu for the development of the Mycobacterium (M.) tuberculosis, the main causative agent of tuberculosis (TB) [2]. Breast tuberculosis affects commonly women in reproductive age and the clinical presentation is often misleading, mimicking a pyogenic abscess or a malignant breast tumor [3, 4], hence the need of a correct diagnosis for an appropriate management of patients. The radiological techniques are not always accurate, as BTB can also mimic a malignant tumor [3, 5, 6]. Biological techniques, such as pus culture or the search for acid-fast bacilli by Ziehl-Neelsen staining, are less sensitive and time-consuming [1, 2]. The polymerase chain reaction (PCR) technique is very sensitive, but expensive and not affordable in poor areas where TB is endemic [2]. The histopathological examination provides usually the accurate diagnosis of TB by showing typical necrotizing granulomas and by excluding all differential diagnosis especially malignant tumors [1, 2, 7]. The management of BTB relies mainly on a standard antibiotherapy combining many drugs, and the surgical treatment is rarely required [2, 7]. The aim of our current study is to report about a rare location of a common disease (breast tuberculosis) and to highlight the major diagnostic role of the pathology in this rare location, in order to provide appropriate management for the patients.

Case presentation

Medical records of all patients histologically diagnosed with breast tuberculosis were retrospectively collected at the Department of Pathology of Hassan II University Hospital of Fès, Morocco (from 2006 to 2017). The diagnosis of BTB was rendered when the histological examination showed typical lesions consisting of granulomas associated with typical caseous necrosis (Figs. 1 and 2). Cases with granulomatous lesions without caseous necrosis have been excluded.
Fig. 1

Histological image of breast tuberculosis showing a necrotizing granulomatous lesion (hematoxylin eosin stain × 100) (patient 5)

Fig. 2

A higher magnification showing areas of caseous necrosis, epithelioid cells, and giant multinucleated cells, surrounded by lymphocytes (hematoxylin eosin stain × 200)

Histological image of breast tuberculosis showing a necrotizing granulomatous lesion (hematoxylin eosin stain × 100) (patient 5) A higher magnification showing areas of caseous necrosis, epithelioid cells, and giant multinucleated cells, surrounded by lymphocytes (hematoxylin eosin stain × 200) The mean age of our five cases was 40.6 years (range of 21–59 years), and all patients were females. All cases had unilateral BTB, with the left side mostly affected (3 cases out of 5) (Table 1). Two patients presented with abscessed lesions, while the remaining three cases presented with breast lumps and a suspicion of malignancy on imaging techniques with lesions categorized as BI-RADS 4 (breast imaging reporting and data system). Of these patients, two had concomitant axillary lymphadenopathy (patients 4 and 5). The histological diagnosis has been made on three biopsy specimens, one excisional biopsy specimen, and one lumpectomy specimen. The diagnosis of TB on axillary lymph nodes (LN) has been performed on biopsy for patient 4 and on fine-needle aspiration (FNA) for patient 5.
Table 1

Clinicopathological features of our patients diagnosed with breast tuberculosis

CasesAge/gender (years)Clinical presentationOther involved sitesSuspicion of malignancySideSpecimensTreatment
140/FAbscessLeftBiopsyDrainage + ATB
238/FLumpBI-RADS 4LeftBiopsyATB
321/FAbscess-fistulaRightBiopsyDrainage + ATB
445/FLumpAxillary LNBI-RADS 4LeftBiopsyATB
559/FLumpAxillary LNBI-RADS 4RightLumpectomySurgery + ATB

F female, LN lymph node, BI-RADS breast imaging reporting and data system, ATB antibiotherapy

Clinicopathological features of our patients diagnosed with breast tuberculosis F female, LN lymph node, BI-RADS breast imaging reporting and data system, ATB antibiotherapy All patients have received the standard antibiotherapy consisting of a combination of antibiotics (2 months of rifampicin, isoniazid, and pyrazinamide, followed by 4 months of rifampicin and isoniazid). Surgical drainage has been performed for patients with breast abscess (patients 1 and 2). Surgical treatment has been performed (lumpectomy) for patient 5. All patients have been successfully treated after the completion of the 6 months standard ATB, with no residual disease.

Discussion

We report herein cases of BTB in Fès, Morocco, an endemic country where the incidence of TB in 2008 was 81 per 100,000 overall, with 28,000 new cases each year [8, 9]. Breast tuberculosis is very rare even in endemic countries [2, 5]. The breast gland is not an ideal site for the survival and multiplication of Mycobacterium tuberculosis [2]. This bacterium seems to reach the breast by several ways: lymphatic or hematogenous route and direct inoculation from adjacent structures (ribs, pleura, lung) [1-4]. The inoculation by retrograde lymphatic route seems to be a more suitable theory as often patients with BTB have an associated lymph node TB [3, 6]. In our series, two patients (40%) had concomitant axillary lymph node TB. In a large series of 46 cases of BTB, Kilic et al. have found eight cases (17.4%) with axillary lymphadenopathy [3]. The clinical presentation of BTB is usually associated with breast pain, breast nodule, abscess, or nipple discharge [1, 3, 6]. More often, BTB affects women in reproductive age, men are very rarely affected [2, 7]. The disease is often unilateral, very rarely bilateral [3]. Patients with breast nodules often present with misleading clinical and radiological aspects, with suspicion of malignancy [3, 4, 6]. Kilic et al. reported in their series that 34.8 and 43.5% of patients presented respectively with clinical and radiological suspicion of malignancy (BI-RADS 4 or 5) [3]. In our cases, three patients (60%) presented with radiological suspicion of malignancy (BI-RADS 4). For adequate management, a correct diagnosis of BTB should be performed. Biological methods, such as acid-fast stain (Ziehl-Neelsen stain) or M. tuberculosis culture, lack sensitivity because BTB lesions are often pauci-bacillary [1, 2, 10]. Molecular techniques like polymerase chain reaction (PCR) are very sensitive but are expensive and not affordable in poor areas where TB is endemic [2]. Pathological examination seems to be more sensitive and less expensive and less time-consuming. The core needle biopsy is more sensitive than cytological method (fine needle aspiration) [2, 10]. However, the histopathological examination of BTB should show typical TB lesions consisting of granulomas associated with typical caseous necrosis. Differential histological diagnoses include several breast lesions that can harbor granulomatous lesions without caseous necrosis: idiopathic granulomatous mastitis, breast sarcoidosis, Wegener granulomatosis, etc. [2]. In our series, all five cases showed granulomas with typical caseous necrosis. The biopsy in one patient (patient 5) failed at first to show caseous necrosis, but it has been repeated and then showed typical TB lesions. The management of BTB relies mainly on a standard antibiotherapy combining many drugs (classically, 2 months of rifampicin, isoniazid, and pyrazinamide with or without ethambutol, followed by 4 months of rifampicin and isoniazid). A surgical treatment is associated when there are abscesses or important tissue destruction [1–3, 7, 11].

Conclusion

Breast tuberculosis is a very rare form of extrapulmonary tuberculosis even in endemic areas. The diagnosis is challenging as clinical and radiological presentations are misleading. Pathology is a valuable diagnostic tool that can achieve a correct diagnosis as sometimes biological techniques (culture, PCR) are time-consuming, more expensive, and not conclusive.
  11 in total

1.  Breast tuberculosis mimicking other diseases.

Authors:  Gian Franco Morino; Giovanna Rizzardi; Federico Gobbi; Marco Baldan
Journal:  Trop Doct       Date:  2007-07       Impact factor: 0.731

2.  Tuberculosis of the breast: 10 years' experience in one institution.

Authors:  T L Lin; S Y Chi; J W Liu; F F Chou
Journal:  Int J Tuberc Lung Dis       Date:  2010-06       Impact factor: 2.373

Review 3.  Breast Tuberculosis.

Authors:  Durganna Thimmappa; M N Mallikarjuna; Abhishek Vijayakumar
Journal:  Indian J Surg       Date:  2015-07-01       Impact factor: 0.656

4.  Breast tuberculosis at a tertiary care centre: a retrospective analysis of 22 cases.

Authors:  Megha Tandon; Pankaj Panwar
Journal:  Breast Dis       Date:  2014

5.  Clinical, diagnostic and therapeutic management of patients with breast tuberculosis: Analysis of 46 Cases.

Authors:  Murat Ozgur Kilic; Cemile Sağlam; Filiz D Ağca; Serdar G Terzioğlu
Journal:  Kaohsiung J Med Sci       Date:  2016-01-21       Impact factor: 2.744

6.  Breast tuberculosis: report of eight cases.

Authors:  Mohsen Fadaei-Araghi; Loabat Geranpayeh; Shirin Irani; Reza Matloob; Soheil Kuraki
Journal:  Arch Iran Med       Date:  2008-07       Impact factor: 1.354

Review 7.  Tuberculosis of the breast: analysis of 20 cases and a literature review.

Authors:  B B da Silva; P V Lopes-Costa; C G Pires; J D Pereira-Filho; A R dos Santos
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-03-06       Impact factor: 2.184

8.  Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco.

Authors:  Kelly E Dooley; Ouafae Lahlou; Iraqi Ghali; Janine Knudsen; My Driss Elmessaoudi; Imad Cherkaoui; Rajae El Aouad
Journal:  BMC Public Health       Date:  2011-02-28       Impact factor: 3.295

9.  Treatment default amongst patients with tuberculosis in urban Morocco: predicting and explaining default and post-default sputum smear and drug susceptibility results.

Authors:  Imad Cherkaoui; Radia Sabouni; Iraqi Ghali; Darya Kizub; Alexander C Billioux; Kenza Bennani; Jamal Eddine Bourkadi; Abderrahmane Benmamoun; Ouafae Lahlou; Rajae El Aouad; Kelly E Dooley
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

10.  Breast tuberculosis in northeast Iran: review of 22 cases.

Authors:  Behnaz Khodabakhshi; Fatemeh Mehravar
Journal:  BMC Womens Health       Date:  2014-05-31       Impact factor: 2.809

View more
  1 in total

1.  Breast Tuberculosis in Women: A Systematic Review.

Authors:  Gianluca Quaglio; Damiano Pizzol; Petros Isaakidis; Arianna Bortolani; Francesca Tognon; Claudia Marotta; Francesco Di Gennaro; Giovanni Putoto; Piero L Olliaro
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.